glp 1 ibd More encouraging news about GLP-1 medications. New research presented at ASCO found that patients with inflammatory bowel disease (IBD) who used GLP- receptor agonists had a 51% lower odds of developing colorectal GLP-1 Medications: Reimagining the Treatment

Nausea, vomiting, constipation, and appetite suppression occur with semaglutide, tirzepatide, and retatrutide, though timing and severity vary

In TM, ginger is used to treat HTN in Ethiopia (57, 84), Indonesia (562), Palestine (171), Senegal (280), and Nigeria (229)

References (this section): NEJM (2023): Retatrutide Phase 2 trial in obesity (mechanism + outcomes context) Eli Lilly: Phase 2 retatrutide results published in NEJM Retatrutide clinical trials (TRIUMPH program): whats being studied Searches like retatrutide clinical trials and retatrutide trial sign up usually point to the sponsors Phase 3 program (often referred to as the TRIUMPH program) plus other listings in official registries

Available at: fertility-smart.net/fertilitysmart-fertility-pills-for-women

27 TieuK.PerierC.CaspersenC.TeismannP.WuD